Economists, Docs Back Actavis In Namenda Injunction Row
A slew of economists, physicians and drug industry groups have urged the Second Circuit to overturn the New York attorney general's injunction requiring Actavis PLC to continue selling a version of...To view the full article, register now.
Already a subscriber? Click here to view full article